QNRX

Conviction 25HealthcareScan · Thu, Sep 24, 2026

Three outside down

Quoin Pharmaceuticals Ltd. (QNRX) closed at $6.30 (-6.67%) on Sep 24, 2026. Its latest daily candle is a three outside down. Price is above its 50-day and below its 200-day moving average. RSI(14) 49, RS Rating 95, -71.8% from its 52-week high, -55.3% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

QNRX$6.30-6.67%

ResistanceSupportVol 14Insider buy

Vol MA14 60.53K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Quoin Pharmaceuticals Ltd.PHARMACEUTICAL PREPARATIONSwww.quoinpharma.com ↗

Price6.30

Change-6.67%

Gap+2.96%

Rel volume0.09×

Avg volume1.68M

Avg $ vol10.36M

SMA 206.76

SMA 505.56

SMA 2007.17

Price vs 50+13.23%

Price vs 200-12.11%

MA stackmixed

50/200 cross—

Supertrendup · 5.35

RSI (14)49

MACD hist-0.11

MACD crossbear · 6d

Stoch %K / %D2 / 24

ADX (14)28

+DI / −DI23 / 22

RSI divergence—

MACD divergence—

ATR %9.48%

ADR %10.11%

52w high22.30

52w low3.25

From 52w high-71.75%

Above 52w low+93.85%

New 52w highNo

SqueezeOff

Bollinger width31.07%

%B0.28

Donchian pos45.62%

Donchian high8.25

Donchian low4.66

AVWAP (52w high)10.61

vs AVWAP high-40.60%

AVWAP (52w low)5.97

vs AVWAP low+5.53%

OBV trendUp

Chaikin MF (20)-0.77

Today vs 20d0.09×

Avg vol (14d)60.53K

Avg vol (20d)1.68M

Avg $ vol (20d)10.36M

Market cap12.65M

RS Rating95 / 99

RS 3m (vs SPY)+45.51%

RS 6m (vs SPY)-48.86%

RS line new highNo

Trend template3/8

Technical rank44.4

1 week-10.13%

1 month+24.26%

3 months+50.00%

6 months-32.04%

1 year-12.13%

YTD-55.26%

P/E-0.80

P/B3.22

P/S—

P/FCF—

EPS—

Div yield—

ROE-401.88%

ROA-132.04%

Debt/Eq—

Current1.76

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-76.34%

Price target25.00

Target upside296.83%

Analyst ratingBuy

Institutional1.85%

Ent. value8.81M

Revenue—

Net income-5.37M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out2.01M

Employees6

ListedThu, Oct 28, 2021

Free float857.14K

Float %42.7%

Short interest526.65K

Days to cover0.2d

Short volume21.0%

Squeeze score41 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.90 vs −$1.83

Last surprise-3.8% miss

Setup gradeD

Conviction25 / 100

Pattern quality—

Tech rank44.4 / 100

Group rank59 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmThree outside down

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in QNRX

All disclosures →

No recent disclosed trades by Congress in QNRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in QNRX · open-market 2 buys

Insider	Side	Shares	Value	Traded	Filed
Carter Denise P. Chief Operating Officer · Ordinary Warrants (Right to Buy) · 2026-08-31	Buy	10.24K	—	2026-08-31	2026-09-01
Carter Denise P. Chief Operating Officer · ADSs · 2026-08-31	Buy	20.49K	$100K	2026-08-31	2026-09-01
Culverwell Anthony James Director · ADSs · 2026-08-27	Grant	31.35K	$161K	2026-08-27	2026-08-28
LANGER DENNIS Director · ADSs · 2026-08-27	Grant	34.53K	$178K	2026-08-27	2026-08-28

SEC filings

EDGAR filings in QNRX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

QNRX

Recent news

Get daily signals & real-time alerts.